Company Search:
Advanced Search
Sponsored Links
Miraca Holdings Incorporated Company Snapshot
Miraca Holdings Incorporated operates in the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Miraca Holdings Incorporated with three other pharmaceutical manufacturers in Asia: Falco Holdings Co Ltd (2017 sales of 45.97 billion Japanese Yen [US$416.04 million] of which 61% was Medical Test), Dr. Lal PathLabs Ltd of India (9.12 billion Indian Rupees [US$142.51 million] of which 100% was Healthcare), and BML Inc (111.24 billion Japanese Yen [US$1.01 billion] of which 95% was Testing business).

Sales Analysis. Miraca Holdings Incorporated reported sales of ¥204.25 billion (US$1.85 billion) for the fiscal year ending March of 2017. This represents a decrease of 3.5% versus 2016, when the company's sales were ¥211.74 billion. Contributing to the drop in overall sales was the 6.7% decline in Clinical Medical Check, from ¥45.79 billion to ¥42.70 billion. There were also decreases in sales in Clinical Examination (down 3.1% to ¥132.94 billion) and Healthcare (down 0.8% to ¥28.61 billion) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Miraca Holdings Incorporated
  Stock Performance Chart for Miraca Holdings Incorporated
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 5,000.00
(Figures in Japanese Yen)
1 Week 0.6%   13 Weeks 2.8%  
4 Weeks -4.2%   52 Weeks -5.7%  
Miraca Holdings Incorporated Key Data:
  Ticker: 4544 Country: Japan
  Exchanges: TYO Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2017 Sales 204,245,000,000
(Year Ending Jan 2018).
Employees: 6,116
  Currency: Japanese Yen Market Cap: 285,365,125,000
  Fiscal Yr Ends: March Shares Outstanding: 57,073,025
  Share Type: Common Closely Held Shares: 136,360
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.